Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry

Erglis, A., Mintale, I., Latkovskis, G., Balode, I., Jegere, S., Bajare, I., Rozenbergs, A., Greenlaw, N., Ferrari, R. and Steg, P. G. (2015) Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: analysis of the CLARIFY registry. Medicina, 51(4), pp. 240-246. (doi:10.1016/j.medici.2015.05.004) (PMID:26424189)

[img]
Preview
Text
112830.pdf
Available under License Creative Commons Attribution Non-commercial No Derivatives.

381kB

Abstract

Background and objective Management of outpatients with stable coronary artery disease (CAD) is important in secondary prevention. The objective was to describe differences in the characteristics of CAD patients in Latvia compared with other countries. Materials and methods CLARIFY is an ongoing international, prospective, observational, longitudinal registry of outpatients with CAD. Data regarding treated outpatients with established CAD from the CLARIFY registry in Latvia (n = 120) were compared with those from the rest of Central-Eastern Europe (CEE) (n = 2888) and worldwide (n = 33,163). Results Patients in Latvia had a larger waist circumference (101 [95–109] vs. 99 [91–106] in CEE, 96.5 [88–105] cm worldwide; P = 0.023 and P < 0.001, respectively) and higher blood pressure (systolic: 138.28 ± 17.13 vs. 133.77 ± 16.47 in CEE and 130.97 ± 16.65 mm Hg worldwide, P = 0.003 and P < 0.001; diastolic: 82.98 ± 8.58 vs. 80.01 ± 9.61 in CEE and 77.22 ± 9.97 mm Hg worldwide, P < 0.001 and P < 0.001, respectively). Body mass index in Latvia did not differ significantly from that in CEE (P = 0.422), but was higher than worldwide (28.8 [26.2–32.0] vs. worldwide 27.3 [24.8–30.3] kg/m2, P < 0.001). The history of percutaneous coronary intervention was more frequent in Latvia (74.17% vs. 59.34% in CEE and 58.61% worldwide, P = 0.001 and P < 0.001, respectively). Latvian patients more frequently used aspirin (97.50% in Latvia vs. 89.75% in CEE and 87.64% worldwide, P = 0.005 and P = 0.001, respectively). Conclusions Latvian CAD patients are well managed in terms of aspirin use and frequency of percutaneous coronary intervention. Control of obesity and high BP is poorer and needs further improvement.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Greenlaw, Miss Nicola
Authors: Erglis, A., Mintale, I., Latkovskis, G., Balode, I., Jegere, S., Bajare, I., Rozenbergs, A., Greenlaw, N., Ferrari, R., and Steg, P. G.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Robertson Centre
Journal Name:Medicina
Publisher:Kauno Medicinos Universitetas
ISSN:1010-660X
ISSN (Online):1648-9144
Copyright Holders:Copyright © 2015 Lithuanian University of Health Sciences
First Published:First published in Medicina 51(4):240-246
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record